Publication | Closed Access

Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells

Breast OncologyMedicineBreast CancerTumor TargetingAnti-cancer AgentAnti-tumor ActivityPharmacologyCell BiologyTumor MicroenvironmentTumor BiologyCancer Growth